NO20055137L - Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer - Google Patents

Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Info

Publication number
NO20055137L
NO20055137L NO20055137A NO20055137A NO20055137L NO 20055137 L NO20055137 L NO 20055137L NO 20055137 A NO20055137 A NO 20055137A NO 20055137 A NO20055137 A NO 20055137A NO 20055137 L NO20055137 L NO 20055137L
Authority
NO
Norway
Prior art keywords
macrolide
treatment
local anesthetic
combination
skin diseases
Prior art date
Application number
NO20055137A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055137D0 (no
Inventor
Maximillan Grassberger
Stefan Hirsch
Nabila Sekkat
Carl-Martin Weiss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055137D0 publication Critical patent/NO20055137D0/no
Publication of NO20055137L publication Critical patent/NO20055137L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20055137A 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer NO20055137L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307869.8A GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003515 WO2004087144A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases

Publications (2)

Publication Number Publication Date
NO20055137D0 NO20055137D0 (no) 2005-11-02
NO20055137L true NO20055137L (no) 2006-01-04

Family

ID=9956231

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055137A NO20055137L (no) 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Country Status (13)

Country Link
US (1) US20060110448A1 (es)
EP (1) EP1613317A1 (es)
JP (1) JP2006522061A (es)
CN (1) CN1771036A (es)
AU (1) AU2004226823A1 (es)
BR (1) BRPI0409207A (es)
CA (1) CA2521261A1 (es)
GB (1) GB0307869D0 (es)
IS (1) IS8106A (es)
MX (1) MXPA05010709A (es)
NO (1) NO20055137L (es)
RS (1) RS20050752A (es)
WO (1) WO2004087144A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR102141441B1 (ko) * 2018-06-28 2020-08-05 이환석 무출혈 무통필름
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766245A (en) * 1954-09-03 1957-01-16 Lilly Co Eli Therapeutic preparations containing erythromycin
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
PL184750B1 (pl) * 1994-10-26 2002-12-31 Novartis Ag Kompozycja w postaci emulsji do stosowania miejscowego
CN1158258A (zh) * 1996-12-11 1997-09-03 李志辉 秦云创伤外用药
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6120792A (en) * 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
JP2001288086A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 皮膚疾患の治療用又は予防用外用剤
JP2001288085A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 乾癬の治療用又は予防用外用剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
WO2002062353A1 (en) * 2001-02-05 2002-08-15 Marie Madeline Wharton Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
RU2195279C1 (ru) * 2001-07-10 2002-12-27 Тульский государственный университет Способ лечения отморожений
CN1189193C (zh) * 2001-09-10 2005-02-16 黄家伶 烧伤药膏
CN1197576C (zh) * 2002-08-30 2005-04-20 孙万一 治疗性病疣的药物及其制备方法

Also Published As

Publication number Publication date
IS8106A (is) 2005-10-31
WO2004087144A1 (en) 2004-10-14
AU2004226823A1 (en) 2004-10-14
MXPA05010709A (es) 2005-12-12
EP1613317A1 (en) 2006-01-11
CN1771036A (zh) 2006-05-10
CA2521261A1 (en) 2004-10-14
US20060110448A1 (en) 2006-05-25
JP2006522061A (ja) 2006-09-28
RS20050752A (en) 2007-11-15
NO20055137D0 (no) 2005-11-02
BRPI0409207A (pt) 2006-03-28
GB0307869D0 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
NO20055136L (no) Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
NO20054988L (no) Preparater og metoder for behandling av cancer
WO2009061916A3 (en) Benzodiazepinone compounds useful in the treatment of skin conditions
WO2007065289A3 (en) 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
NO20081041L (no) PPar aktive forbindelser
NO20073068L (no) Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
WO2005079143A3 (en) Topical formulations for the treatment of skin conditions
WO2006015263A3 (en) Lonidamine analogs
DK1392131T3 (da) Huddiætfoder til kæledyr
MX353712B (es) Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
BRPI0507463A (pt) uso de glufosfamide e gemcitabine , produto, e, combinação de glufosfamide e gemcitabine
NO20055137L (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
GEP20135900B (en) Emollient composition
BRPI0518700B8 (pt) combinação contendo vegf-trap, 5-fluorouracila e ácido folínico
EA200702026A1 (ru) Лечение или предупреждение зуда
NO20055179L (no) Synergistiske kombinasjoner av makrolid T-celle modulator eller immunosupressivt stoff og et retionid
BR0315195A (pt) Composições farmacêuticas e usos das composições
NO20055170L (no) Organiske forbindelser
BRPI0415225A (pt) composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos
WO2006128169A3 (en) Inhibition of monocyte survival, differentiation, or proliferation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application